Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients.

Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients. — المؤلف: Lavrov, Alexander V — BMC medical genomics 20200513

المؤلف
Lavrov, Alexander V
النشر
BMC medical genomics 20200513
الوصف
37 p.
الموضوعات
Adult؛ Aged؛ Biomarkers, Tumor؛ Exome؛ Female؛ Genotype؛ Humans؛ Imatinib Mesylate